Navigation Links
Leukemia Patients Taking Gleevec Achieve 'Normal' Death Rate
Date:3/22/2011

TUESDAY, March 22 (HealthDay News) -- The death rate of patients with chronic myeloid leukemia who took Gleevec and were in remission two years after treatment was similar to the death rate in the general population, a new study shows.

Italian researchers collected data on 832 patients who were taking Gleevec (imatinib) for up to eight years and found that 20 patients died during the follow-up period. That death rate of 4.8 percent, however, is similar to what would be expected in the general population.

Only six deaths were related to chronic myeloid leukemia (CML), the researchers noted.

Serious adverse events such as cardiovascular and digestive problems were reported in 139 patents, but only 27 cases (19 percent) were considered to be related to Gleevec, according to the study.

Other adverse events frequently connected to Gleevec included muscle cramps, weakness, edema, skin fragility, diarrhea, and tendon or ligament lesions. Nineteen patients (2.3 percent) stopped taking Gleevec due to side effects, with half switching to another drug.

Patients taking Gleevec "frequently suffer from side effects that are non-serious but can nonetheless reduce their quality of life," the researchers wrote.

The study authors disclosed no conflicts of interest, noting that their independence from pharmaceutical interests was a major strength of the study.

The researchers also noted the "importance of a good patient-provider relationship, in which side effects are easily communicated and addressed to reduce/avoid non-compliance."

In an accompanying editorial, Dr. B. Douglas Smith of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, noted "the astounding effect [imatinib] has had on the clinical course of this disease."

However, he wrote that many patients in the study had been treated first with interferon, which may have been a factor in their remissions. For this reason,
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Less Is More With Acute Myeloid Leukemia Drug
2. When leukemia returns, gene that mediates response to key drug often mutated
3. A small subset of normal white blood cells gives rise to a rare leukemia, study shows
4. Scientists bioengineer a protein to fight leukemia
5. Southampton scientists begin patient trials of new leukemia cancer vaccine
6. Discovery of a gene associated with a leukemia mostly affecting children
7. MicroRNA-TP53 circuit connected to chronic lymphocytic leukemia
8. Gene Activity May Affect Acute Myeloid Leukemia Outcome
9. Intensive chemotherapy can dramatically boost survival of older teenage leukemia patients
10. Researchers make critical leukemia stem cell discovery
11. New therapies and gene target advance the treatment and understanding of hard-to-treat leukemias
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Leukemia Patients Taking Gleevec Achieve 'Normal' Death Rate
(Date:9/18/2014)... Limited spots remain at Becker's Healthcare's ... spots are still available for Becker's ASC 21st Annual ... October 23-25, 2014 at the Swissotel Chicago. , Only ... Officer Strategy Roundtable on November 4, 2014 at the ... Becker's Hospital Review Chief Executive Officer Strategy Roundtable on ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 It is that ... in health and wellness. Once again, Evensong Spa ... Week by offering three services at a special $50 rate ... managed by Marcus Hotels & Resorts , is the ... event encouraging Americans to embrace health and wellness by experiencing ...
(Date:9/18/2014)... is good for you. But new research from University ... added benefit for cancer patients undergoing chemotherapy. , Their ... that combining exercise with chemotherapy shrunk tumors more than ... in the School of Nursing and director of the ... senior author on the study, which appears in the ...
(Date:9/18/2014)... 18, 2014 Thousands of college and ... their shared fundraising impact on 127 member Children’s ... The first-ever Dance Marathon Day will officially kick off ... to be raised by college and high school students ... generated through Dance Marathon campus programs help provide medical ...
(Date:9/18/2014)... don,t worry, it,s a good thing! As scientists have ... bad. Many active enzymes and bacteria are merely benign, ... important part of our digestive system or can help ... an opportunistic yeast pathogen and model organism for research, ... ecosystem. However, when our immune system is stressed on ...
Breaking Medicine News(10 mins):Health News:Limited Spots Remain at Becker's Upcoming ASC and Hospital Conferences 2Health News:Evensong Spa Celebrates Spa Week with $50 Services 2Health News:Evensong Spa Celebrates Spa Week with $50 Services 3Health News:Exercise boosts tumor-fighting ability of chemotherapy, Penn team finds 2Health News:250 Campuses Usher in School Year of Saving Kids’ Lives During First-Ever “Dance Marathon Day” on Sept. 25 2Health News:Everything in moderation: Micro-8 to study regulating pathogens in space 2Health News:Everything in moderation: Micro-8 to study regulating pathogens in space 3
... answered a central question in cancer biology: whether normal ... are immature cells that can renew themselves and give ... of body tissues. In recent years, researchers have developed ... stem cells. , Like a brand-name product instantly ...
... Ariz., Dec. 17 Pyramid Developers, a leader in ... master planned projects has joined with Scottsdale based Dr. Theresa ... for "Of the Place, Of the People" reflecting the focus ... creation of health and wellness focused sustainable communities. , ...
... Canadians are becoming aware of the prevalence of mental ... well equipped are we to help the many people ... the December issue of the Canadian Journal of ... for mental health and substance use services to adequately ...
... LifeBanc, the nonprofit,organ and tissue recovery organization for Northeast ... conference announcing the first,near total face transplant in the ... The following statement is from LifeBanc Chief Executive Officer ... keeping with LifeBanc,s mission of helping to improve and ...
... CITY, Dec. 17 Dynatronics Corporation (Nasdaq: ... directors and the execution of an agreement with a ... strategic planning and improved corporate profitability. On December 15, ... Capital Partners for consulting services through its principal, Mark ...
... Policymakers, the media, and the public should focus on 20 ... and well-being of Americans, says a new report from the ... compared over time, these 20 indicators will also help Americans ... effectiveness of public health and care systems, the report says. ...
Cached Medicine News:Health News:Molecular marker identifies normal stem cells as intestinal tumor source 2Health News:Pyramid Developers and Dr. Ramsey's Center for Natural Healing Announce Formation of Community Health and Wellness Planning Collaborative. 2Health News:Pyramid Developers and Dr. Ramsey's Center for Natural Healing Announce Formation of Community Health and Wellness Planning Collaborative. 3Health News:Pyramid Developers and Dr. Ramsey's Center for Natural Healing Announce Formation of Community Health and Wellness Planning Collaborative. 4Health News:National rates of co-occurring substance use and mental disorders call for better service integration 2Health News:National rates of co-occurring substance use and mental disorders call for better service integration 3Health News:LifeBanc Assists Cleveland Clinic in First Near Total Face Transplant in the United States 2Health News:Dynatronics Announces Changes to Board and Launches Operational Improvement Process 2Health News:Stakeholders and public should use 20 specific health indicators 2Health News:Stakeholders and public should use 20 specific health indicators 3
(Date:9/18/2014)... Texas , Sept. 18, 2014  Casen Buswell has ... and muscles to harden.  His case is one of only ... the world.  The only hospital in the United ... the world, offering treatment with the dual wave-length laser, is ... San Antonio . Using a laser available in ...
(Date:9/18/2014)... Sept. 18, 2014   Fruit Street Health ... initial seed round of funding. The ... by a series of individual investors, the majority of ... in the initial round are; Houston Cardiology Consultants ... Urologist Stacy Childs, Rapha Family Medicine Practice Owner ...
(Date:9/18/2014)... Pharma IQ, after huge demand ... Countdown calendar to cover the years 2014 - 2018 ... shows the serialisation requirements around the globe and the ... For companies dealing with international markets, serialisation ... they will have to comply with new regulations coming ...
Breaking Medicine Technology:Methodist Children's Hospital In San Antonio, TX Only Hospital In The U.S. Treating Rare Vascular Condition With Dual Wave-Length Laser 2Fruit Street Health Secures First Round Of Seed Funding Led By Group Of Medical Industry And Technology Leaders 2Fruit Street Health Secures First Round Of Seed Funding Led By Group Of Medical Industry And Technology Leaders 3Pharma IQ Displays Worldwide Serialisation Deadlines in their 2014 - 2018 Countdown Calendar 2
... Dec 13, 2011 MedEfficiency, Inc., a medical ... manufacturing, and marketing of medical devices for treating ... that it has been awarded a Veteran,s Administration ... will be listed as a government-approved vendor.  ...
... More than 60,000 young children end up in emergency ... parents or caregivers were not looking. To remind parents ... the Centers for Disease Control and Prevention (CDC) and ... partnership with the PROTECT Initiative , today launched ...
Cached Medicine Technology:MedEfficiency Awarded VA Contract for Its Total Contact Casting Products 2CDC and CHPA Educational Foundation Launch Up and Away and Out of Sight 2CDC and CHPA Educational Foundation Launch Up and Away and Out of Sight 3
Substrate Plasma for Factor V Assay by STA© Analyzers. Freeze-dried human plasma, artificially depleted of factor V....
Substrate Plasma for Factor VIII Assay by STA© Analyzers. Freeze-dried human plasma from which factor VIII has been removed by selective immuno-adsorption....
Immuno-turbidimetric Assay of von Willebrand Factor (vWF) Antigen by STA© Analyzers. Microlatex particles coated with rabbit anti-human vWF antibodies....
Colorimetric Assay of Plasminogen Activity by STA© Analyzers....
Medicine Products: